Relative incidences and outcomes of Clostridium difficile infection following transplantation of unrelated cord blood, unrelated bone marrow, and related peripheral blood in adult patients: a single institute study
暂无分享,去创建一个
N. Matsuno | A. Yoneyama | H. Araoka | S. Nakao | A. Takami | K. Ishiwata | N. Uchida | K. Hosokawa | S. Taniguchi | K. Masuoka | S. Takagi | M. Tsuji | A. Wake | S. Makino | H. Yamamoto | Y. Asano‐Mori
[1] H. Greinix,et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease , 2015 .
[2] Daniel Wolff,et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[3] Christy A. Varughese,et al. Antibiotic-Associated Diarrhea , 2013, Journal of pharmacy practice.
[4] Y. Kanda,et al. Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.
[5] R. Owens. Clostridium difficile-Associated Disease , 2012, Drugs.
[6] R. Porcher,et al. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[7] M. Kami,et al. Allogeneic cord blood transplantation for adult acute lymphoblastic leukemia: retrospective survey involving 256 patients in Japan , 2012, Leukemia.
[8] G. Alangaden,et al. Recent epidemiology of Clostridium difficile infection during hematopoietic stem cell transplantation , 2011, Clinical transplantation.
[9] Y. Arakawa,et al. Typing of Clostridium difficile isolates endemic in Japan by sequencing of slpA and its application to direct typing. , 2010, Journal of medical microbiology.
[10] D. Gerding,et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) , 2010, Infection Control & Hospital Epidemiology.
[11] J. Dipersio,et al. Clostridium difficile‐associated disease in allogeneic hematopoietic stem‐cell transplant recipients: risk associations, protective associations, and outcomes , 2010, Clinical transplantation.
[12] B. Currie,et al. Incidence of Clostridium difficile Infection in Patients with Acute Leukemia and Lymphoma after Allogeneic Hematopoietic Stem Cell Transplantation , 2010, Infection Control & Hospital Epidemiology.
[13] H. Einsele,et al. Life-Threatening Infection Caused by Daptomycin-Resistant Corynebacterium jeikeium in a Neutropenic Patient , 2009, Journal of Clinical Microbiology.
[14] B. Sandmaier,et al. Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[15] M. Remberger,et al. Unrelated cord blood and mismatched unrelated volunteer donor transplants, two alternatives in patients who lack an HLA-identical donor , 2008, Bone Marrow Transplantation.
[16] H. Lazarus,et al. Clostridium difficile-associated disease in human stem cell transplant recipients: coming epidemic or false alarm? , 2008, Bone Marrow Transplantation.
[17] T. Sugihara,et al. Successful treatment of meningoencephalitis caused by methicillin-resistant Staphylococcus aureus with intravenous linezolid in an allogeneic cord blood stem cell transplant recipient , 2008, Scandinavian journal of infectious diseases.
[18] C. Kelly,et al. Update on Clostridium difficile associated disease , 2007, Current opinion in gastroenterology.
[19] R. Owens. Clostridium difficile-associated disease: changing epidemiology and implications for management. , 2007, Drugs.
[20] Chao‐Ping Yang,et al. Fulminant septicaemia caused by multi-drug-resistant Streptococcus mitis following unrelated cord blood transplantation , 2006, Annals of tropical paediatrics.
[21] J. Sierra,et al. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[22] Y. Kanda,et al. Bloodstream infection after umbilical cord blood transplantation using reduced-intensity stem cell transplantation for adult patients. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[23] M. Turner,et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[24] S. Pillai,et al. Linezolid-Resistant Enterococcus faecalis Isolated from a Cord Blood Transplant Recipient , 2004, Journal of Clinical Microbiology.
[25] G. Sanz,et al. Unrelated donor umbilical cord blood transplantation in adults , 2002, Leukemia.
[26] T. Calandra,et al. Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer , 2002 .
[27] J. Winter,et al. Rarity of toxigenic Clostridium difficile infections after hematopoietic stem cell transplantation: implications for symptomatic management of diarrhea , 2002, Bone Marrow Transplantation.
[28] D. Milligan,et al. Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality , 2000, Bone Marrow Transplantation.
[29] D. Gerding,et al. Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection? , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[30] J. Klein,et al. IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE , 1997, British journal of haematology.
[31] C. Surawicz,et al. Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[32] W. Graninger,et al. Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[33] A. Glatt,et al. Clostridium difficile infection associated with antineoplastic chemotherapy: a review. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[34] D. Gerding,et al. PROSPECTIVE RANDOMISED TRIAL OF METRONIDAZOLE VERSUS VANCOMYCIN FOR CLOSTRIDIUM-DIFFICILE-ASSOCIATED DIARRHOEA AND COLITIS , 1983, The Lancet.
[35] B. Greene,et al. 12 MONTH FOLLOW-UP OF MEBENDAZOLE THERAPY FOR ONCHOCERCIASIS , 1981, The Lancet.